These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2825106)

  • 1. Correlation of serum opsonic activity in cystic fibrosis with colonization and disease state: measurement of opsonins to Pseudomonas aeruginosa by neutrophil superoxide anion generation.
    Bender JG; Florman AL; Van Epps DE
    Pediatr Res; 1987 Oct; 22(4):383-8. PubMed ID: 2825106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
    Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency.
    Moss RB; Hsu YP; Sullivan MM; Lewiston NJ
    Pediatr Res; 1986 May; 20(5):453-9. PubMed ID: 3714355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
    Holby N; Olling S
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis.
    Pressler T; Jensen ET; Espersen F; Pedersen SS; Høiby N; Koch C
    Pediatr Pulmonol; 1994 Jan; 17(1):31-40. PubMed ID: 8108174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
    N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
    Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
    Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.
    Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M
    J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.
    Baltimore RS; Mitchell M
    J Infect Dis; 1980 Feb; 141(2):238-47. PubMed ID: 6444976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa.
    Stiver HG; Zachidniak K; Speert DP
    Clin Invest Med; 1988 Aug; 11(4):247-52. PubMed ID: 2971496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
    Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
    Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some bacterial parameters influencing the neutrophil oxidative burst response to Pseudomonas aeruginosa biofilms.
    Jensen ET; Kharazmi A; Høiby N; Costerton JW
    APMIS; 1992 Aug; 100(8):727-33. PubMed ID: 1325804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa.
    McCormick LL; Karulin AY; Schreiber JR; Greenspan NS
    J Immunol; 1997 Apr; 158(7):3474-82. PubMed ID: 9120309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages.
    Cabral DA; Loh BA; Speert DP
    Pediatr Res; 1987 Oct; 22(4):429-31. PubMed ID: 2891100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
    Marshall BC; Carroll KC
    Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between chronic colonization or infection with Pseudomonas aeruginosa and bronchial hyperreactivity in patients with cystic fibrosis].
    Valverde-Molina J; Sánchez-Solís M; Pastor-Vivero MD; García-Marcos L
    Arch Bronconeumol; 2008 Apr; 44(4):180-4. PubMed ID: 18423178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
    JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.